Madrigal Pharmaceuticals

About:

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Website: http://madrigalpharma.com

Twitter/X: MadrigalPharma

Top Investors: Hercules Capital, Bay City Capital

Description:

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases. The company targets the treatment of both niche and prevalent indications, including diabetes, dyslipidemia, and cardiovascular disease.

Total Funding Amount:

$1.59B

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Conshohocken, Pennsylvania, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)madrigalpharma.com

Founders:

Rebecca Taub

Number of Employees:

251-500

Last Funding Date:

2024-03-18

IPO Status:

Public

© 2025 bioDAO.ai